Sam Samad Quest Diagnostics Inc (DGX) insider trading activity

Sam Samad is Executive Vice President & CFO of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 25,741 shares of DGX, which is worth approximately $3.53 Million. The most recent transaction as insider was on Oct 21, 2025, when has been sold 68 shares (Common Stock) at a price of $189.08 per share, resulting in proceeds of $12,857. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.7K

0.26% 3M change

47.06% 12M change

Total Value Held $3.53 Million

SAM SAMAD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 21 2025	BUY Grant, award, or other acquisition	$12,857 $189.08 p/Share	68 Added 0.26%	25,741 Common Stock
Jul 21 2025	BUY Small Acquisition	$12,060 $167.5 p/Share	72 Added 0.28%	25,673 Common Stock
Jul 16 2025	SELL Payment of exercise price or tax liability	$143,658 $169.01 p/Share	850 Reduced 3.21%	25,601 Common Stock
Apr 21 2025	BUY Small Acquisition	$12,167 $164.42 p/Share	74 Added 0.28%	26,451 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$1,335,018 $173.74 p/Share	7,684 Reduced 22.56%	26,377 Common Stock
Mar 04 2025	BUY Grant, award, or other acquisition	$2,412,206 $173.74 p/Share	13,884 Added 28.96%	34,061 Common Stock
Feb 26 2025	SELL Payment of exercise price or tax liability	$149,250 $171.75 p/Share	869 Reduced 4.13%	20,177 Common Stock

Feb 19 2025	SELL Payment of exercise price or tax liability	$174,971 $169.71 p/Share	1,031 Reduced 4.67%	21,046 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	4,538 Added 17.05%	22,077 Common Stock
Jan 29 2025	BUY Small Acquisition	$5,531 $158.04 p/Share	35 Added 0.2%	17,539 Common Stock
Oct 21 2024	BUY Small Acquisition	$5,526 $149.37 p/Share	37 Added 0.21%	17,504 Common Stock
Jul 22 2024	BUY Small Acquisition	$3,086 $146.97 p/Share	21 Added 0.12%	17,467 Common Stock
Jul 16 2024	SELL Payment of exercise price or tax liability	$557,761 $142.65 p/Share	3,910 Reduced 18.31%	17,446 Common Stock
Apr 22 2024	BUY Grant, award, or other acquisition	$3,030 $126.25 p/Share	24 Added 0.11%	21,356 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$82,892 $126.36 p/Share	656 Reduced 2.98%	21,332 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	5,478 Added 19.94%	21,988 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	$2,198 $129.33 p/Share	17 Added 0.1%	16,510 Common Stock
Oct 23 2023	BUY Grant, award, or other acquisition	$2,211 $122.86 p/Share	18 Added 0.11%	16,493 Common Stock
Jul 14 2023	SELL Payment of exercise price or tax liability	$547,963 $140.18 p/Share	3,909 Reduced 19.18%	16,475 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	4,710 Added 18.77%	20,384 Common Stock

Also insider at

ILMN

ILLUMINA, INC. Healthcare

SVP and CFO

IDXX

IDEXX LABORATORIES INC Healthcare

Director

Sam Samad

Executive Vice President & CFO

Westbrook, ME

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account